This company has been marked as potentially delisted and may not be actively trading. F-star Therapeutics (FSTX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock FSTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Astria Therapeutics price target raised to $28 from $26 at OppenheimerNovember 14, 2024 | markets.businessinsider.comLake Street Remains a Buy on Aquestive Therapeutics (AQST)October 25, 2024 | markets.businessinsider.comStarton Therapeutics Announces Successful Feasibility Demonstration of STAR-LLD Using BD Evolve™ On-Body InjectorSeptember 18, 2024 | markets.businessinsider.comBicara Therapeutics Rises 39% in Debut on NasdaqSeptember 15, 2024 | marketwatch.comAnalysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX) and SAGE Therapeutics (SAGE)July 25, 2024 | markets.businessinsider.comBuy Rating for Astria Therapeutics: Promising STAR-0215 Outpaces Competitors with Strategic Trials and Market PotentialMay 10, 2024 | markets.businessinsider.comAstria Therapeutics: Strong Buy Rating on Robust Finances and Promising Clinical TrialsMay 10, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Pliant Therapeutics (PLRX) and Crinetics Pharmaceuticals (CRNX)May 7, 2024 | markets.businessinsider.comAdam22's porn star wife Lena The Plug ADMITS she enjoyed sex with other man MORE than husband'sJuly 20, 2023 | dailymail.co.ukA*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the USJuly 12, 2023 | finance.yahoo.comTwitch star Amouranth reveals she has been diagnosed with 'late stage ovarian failure' at AGE 29 - after 'shrugging off confusing mental and physical symptoms' for MONTHSJuly 11, 2023 | dailymail.co.ukDouglas F. MayoJune 26, 2023 | startribune.comSOchre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of DirectorsJune 2, 2023 | finance.yahoo.comF. Murray Abraham apologizes after sexual misconduct allegationsApril 23, 2023 | sfgate.comF-star Therapeutics (Nasdaq:FSTX) HeadlineTrading was temporarily halted for "FSTX" at 07:03 PM with a stated reason of "News pending."...March 9, 2023 | marketbeat.cominvoX Pharma Completes Acquisition of F-star Therapeutics, Inc.March 8, 2023 | businesswire.comF-star Therapeutics, Inc.: F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX PharmaMarch 7, 2023 | finanznachrichten.deF-star Therapeutics surges as buyer Sino Biopharma gains CFIUS approvalMarch 7, 2023 | msn.comWhy F-Star Therapeutics Shares Are Moving HigherMarch 7, 2023 | msn.comF-star Therapeutics Shares Rally After Cfius Clears Takeover >FSTXMarch 7, 2023 | marketwatch.comF-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX PharmaMarch 7, 2023 | finance.yahoo.comF-Star Therapeutics Blasts Up as Merger Deal Goes ThroughMarch 7, 2023 | msn.comF-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX PharmaMarch 7, 2023 | finance.yahoo.comF-star Therapeutics surges on report sale to Sino Biopharma close to CFIUS approvalMarch 7, 2023 | msn.comGabelli Funds LLC Buys 23,545 Shares of F-star Therapeutics, Inc. (NASDAQ:FSTX)March 2, 2023 | marketbeat.comErgoteles LLC Increases Stake in F-star Therapeutics, Inc. (NASDAQ:FSTX)February 28, 2023 | marketbeat.comF-star Therapeutics jumps as it extends walk date with buyer to `finalize' CFIUS agreementFebruary 25, 2023 | seekingalpha.comF-star Therapeutics Inc Ordinary SharesFebruary 24, 2023 | morningstar.comMF-star Therapeutics jumps as it extends walk date with buyer to `finalize" CFIUS agreementFebruary 23, 2023 | msn.comWhile institutions own 48% of F-star Therapeutics, Inc. (NASDAQ:FSTX), retail investors are its largest shareholders with 49% ownershipFebruary 22, 2023 | finance.yahoo.comInvestors Buy Large Volume of Call Options on F-star Therapeutics (NASDAQ:FSTX)February 17, 2023 | marketbeat.comF-star Therapeutics gains after deal termination date with buyer extended againFebruary 9, 2023 | msn.comF-star Therapeutics gains as buyer Sino Biopharma cancels Shanghai listingFebruary 8, 2023 | msn.comRussell Investments Group Ltd. Grows Stock Holdings in F-star Therapeutics, Inc. (NASDAQ:FSTX)February 7, 2023 | marketbeat.comF-star Therapeutics up 18% as it extends end date of merger with invoX PharmaFebruary 1, 2023 | msn.comF-star Therapeutics, Inc. (NASDAQ:FSTX) Short Interest Down 14.4% in JanuaryJanuary 29, 2023 | marketbeat.comF-star Therapeutics, Inc.: invoX Pharma and F-star Therapeutics issue Joint StatementJanuary 26, 2023 | finanznachrichten.deFSTX F-star Therapeutics, Inc.January 26, 2023 | seekingalpha.comF-star Therapeutics partly pares loss as buyer says in active talks with CFIUS (update)January 26, 2023 | msn.comF-star Therapeutics (Nasdaq:FSTX) HeadlineTrading was temporarily halted for "FSTX" at 03:01 PM with a stated reason of "LULD pause."...January 26, 2023 | marketbeat.comWhy Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJanuary 26, 2023 | msn.comF-star Therapeutics (Nasdaq:FSTX) HeadlineTrading was temporarily halted for "FSTX" at 10:01 AM with a stated reason of "LULD pause."...January 26, 2023 | marketbeat.comF-star Therapeutics (Nasdaq:FSTX) HeadlineTrading was temporarily halted for "FSTX" at 10:01 AM with a stated reason of "LULD pause."...January 26, 2023 | marketbeat.comF-star Therapeutics (Nasdaq:FSTX) HeadlineTrading was temporarily halted for "FSTX" at 10:01 AM with a stated reason of "LULD pause."...January 26, 2023 | marketbeat.comF-star Therapeutics (Nasdaq:FSTX) HeadlineTrading was temporarily halted for "FSTX" at 10:01 AM with a stated reason of "LULD pause."...January 26, 2023 | marketbeat.comJane F. PieriJanuary 23, 2023 | startribune.comSStock Traders Purchase High Volume of F-star Therapeutics Put Options (NASDAQ:FSTX)December 30, 2022 | marketbeat.comF-star Therapeutics (Nasdaq:FSTX) HeadlineTrading was temporarily halted for "FSTX" at 07:12 PM with a stated reason of "News pending."...December 29, 2022 | marketbeat.comWhy Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day SessionDecember 21, 2022 | msn.comShort Interest in F-star Therapeutics, Inc. (NASDAQ:FSTX) Rises By 64.1%December 13, 2022 | marketbeat.com Get F-star Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FSTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FSTX Media Mentions By Week FSTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FSTX News Sentiment▼0.000.92▲Average Medical News Sentiment FSTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FSTX Articles This Week▼00▲FSTX Articles Average Week Get the Latest News and Ratings for FSTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for F-star Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MBX News Today AVTE News Today BIOA News Today ELYM News Today CYBN News Today VIRI News Today OSTX News Today ATNM News Today AADI News Today EGRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FSTX) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTen Bucks, Five Minutes... Could Send You Up to $8K QUARTERLYDOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F-star Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share F-star Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
